Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

Scalp cooling effectively prevents chemotherapy-induced hair loss but requires better pain management.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Chemotherapy can cause significant but usually reversible hair loss, and managing it involves patient education and hair care strategies.

Phenobarbital-loaded chitosan nanoparticles are promising for preventing hair loss from chemotherapy.

Scalp cooling is recommended to prevent chemotherapy-induced hair loss, but no effective drugs are available.

The treatment was effective for advanced non-Hodgkin's lymphomas.

More effective methods are needed to prevent hair loss from chemotherapy.

Low-dose chemotherapy is safer, more effective, and cost-effective than surgery for treating bone lesions in children.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Chemotherapy affects blood vessels in hair follicles, not stem cells, allowing hair regrowth.

Some cancer treatments cause different types of hair loss, but scalp cooling can help prevent it.

Cooling with antioxidants helps protect hair during chemotherapy.

Most pediatric cancer patients at Muhimbili National Hospital in Tanzania experienced side effects from chemotherapy, with nausea, hair loss, and low white blood cell count being the most common.

Topical vasoconstrictors do not reduce chemotherapy effectiveness against leukemia in mice.

Scalp cooling effectively prevents hair loss in breast cancer patients undergoing chemotherapy.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

Chemotherapy for breast cancer often causes significant and lasting hair loss.

Scalp cooling can help prevent hair loss in about half of chemotherapy patients.

Scalp cooling may be less effective for women of color on certain chemotherapy treatments.

Improving hair health and managing conditions can enhance scalp cooling effectiveness in preventing hair loss during chemotherapy.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Scalp cooling reduces chemotherapy-induced hair loss without increasing risk of skin metastases.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

Chemotherapy in children often causes hair loss, nausea, vomiting, and mood swings.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.